Cellmid Limited (CDY) is an Australian life sciences accelerator for indication of multiple diseases. It operates mainly through its wholly owned subsidiaries, Advangen Limited, Kinera and Lyramid Limited, that develop and market innovative novel therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company holds global intellectual properties relating to novel targets midkine and FGF5.
Cellmid Limited operators in Health Care sector and under industry of Biotechnology. The company website is: http://www.cellmid.com.au.
You can also check out dividend history for similar stocks in the same sector as follows:
CDY Dividend Dates
Please click the table header to sort the data.
No Dividend Dates Found